During the past decade, Springfield Neurology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Springfield Neurology" are "Multiple Sclerosis" (2 trials). Many other conditions were trialed in "Springfield Neurology" in a lesser frequency.

Most popular intervention types in "Springfield Neurology" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Encapsulated Baclofen 20 mg" (1 trials), "Fingolimod" (1 trials), "IPX056 10 mg" (1 trials), "IPX056 20 mg" (1 trials) and "IPX056 30 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Springfield Neurology" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Springfield Neurology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Springfield Neurology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Springfield Neurology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".